PT  - JOURNAL ARTICLE
AU  - Abdullah Murhaf Al-Khani
AU  - Mohamed Abdelghafour Khalifa
AU  - Abdulrahman AlMazrou
AU  - Nazmus Saquib
TI  - The SARS-CoV-2 pandemic course in Saudi Arabia: A dynamic epidemiological model
AID  - 10.1101/2020.06.01.20119800
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.01.20119800
4099  - http://medrxiv.org/content/early/2020/06/02/2020.06.01.20119800.short
4100  - http://medrxiv.org/content/early/2020/06/02/2020.06.01.20119800.full
AB  - Objective Saudi Arabia ranks second in the number of coronavirus disease 2019 (COVID-19) cases in the Eastern Mediterranean region. It houses the two most sacred religious places for Muslims: Mecca and Medina. It is important to know what the trend in case numbers will be in the next 4–6 months, especially during the Hajj pilgrimage season.Methods Epidemiological data on COVID-19 were obtained from the Saudi Arabian Ministry of Health, the World Health Organization, and the Humanitarian Data Exchange. A susceptible-exposed-infectious-recovered (SEIR) prediction model was constructed to predict the trend in COVID-19 in Saudi Arabia in the next 6 months.Findings The model predicts that the number of active cases will peak by 20 May 2020. The cumulative infected cases are predicted to reach 59,663 at that time. The total number of infected individuals is estimated reach to 102,647 by the end of the pandemic.Conclusion Our estimates show that by the time the Hajj season commences in Saudi Arabia, the pandemic will be in the midst of its deceleration phase (phase 3). This information will likely be useful to policymakers in their management of the outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received no funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.cfrmortality proportion among the infectedCDCCenters for Disease Control and PreventionCOVID-19coronavirus disease 2019DCMdeterministic compartmental modele.durduration of the exposed statee.numnumber of exposedi.durduration of the infectious statei.numnumber of infectedMERS-CoVMiddle East respiratory syndrome coronavirusp.numnumber of protectedr.numnumber of recoveredR0basic reproduction number s.num: number of susceptibleSARS-CoV 2severe acute respiratory syndrome coronavirus 2SEIRsusceptible, exposed, infectious and recovered infectious disease prediction modelSIRsusceptible, infectious and recovered infectious disease prediction model